You have the right to a FREE PSA blood test from your GP. If you’re Black or have a family history of #ProstateCancer, check your risk using our online Risk Checker below or speak to your GP about a regular test from the age of 45. ➡️ Check your risk: bit.ly/3ckmRBy

This Tuesday, I had the honor of successfully defending my PhD at the KU Leuven titled: "𝐓𝐡𝐞 𝐄𝐦𝐞𝐫𝐠𝐢𝐧𝐠 𝐑𝐨𝐥𝐞 𝐨𝐟 𝐑𝐚𝐝𝐢𝐨𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐢𝐧 𝐇𝐢𝐠𝐡-𝐑𝐢𝐬𝐤 𝐚𝐧𝐝 𝐎𝐥𝐢𝐠𝐨𝐦𝐞𝐭𝐚𝐬𝐭𝐚𝐭𝐢𝐜 𝐏𝐫𝐨𝐬𝐭𝐚𝐭𝐞 𝐂𝐚𝐧𝐜𝐞𝐫." I am immensely grateful to my

External validation of nomograms for predicting lymph node invasion (LNI) in prostate cancer patients with negative PSMA PET-CT. What did we find? The Briganti 2023 nomogram is the most accurate! 📊✅ 🔍 Why does it matter? Extended pelvic lymph node dissection (ePLND) is the

Excellent PhD on oligometastatic prostate cancer and with first results of “full monty” in heavy nodal burden. Bravo ⁦Kato Rans⁩ ⁦steven joniau⁩ ⁦Alison Tree 💙⁩ ⁦Maarten Albersen⁩ ⁦Hein Van Poppel⁩ ⁦Filip Ameye⁩ linkedin.com/posts/kato-ran…

It was a pleasure welcoming colleagues from Liège during the masterclass organized by Coloplast Interventional Urology - Europe ! I thoroughly enjoyed your interest and interaction during mini-PCNL, RIRS, laser endoureterotomy procedures, and case discussions. Big thank you to my entire team AZKlina 🙏

I'm happy to announce that I've been accepted into the YAU Prostate Cancer Working Group! 🤩 Excited to collaborate with YAU members on future research. 🔬🚀 Giancarlo Marra Pawel Rajwa

Fantastic 7 months mentoring my superb endourology fellow Joren Vanthoor ! So proud to see him master PCNL, HoLEP, RIRS, metabolic stone workups, and achieve publication. Best of luck in #Cambridge Oliver Wiseman Tev Aho Excited to follow your career in Belgian endourology!

Vincent De Coninck Joren Vanthoor Tev Aho Marc Claessens Wies Vanderbruggen Urologie Noord Antwerpen Joost Baert steven joniau Laurian Dragos AZKlina We are really looking forward to Joren Vanthoor starting. Not long now… safe travels.

Ieder jaar maakt Newsweek een World's Best Hospitals-ranking op. Dit jaar belandde AZ Delta op de tiende plaats! 🤩 Dankjewel aan alle artsen en medewerkers om elke dag een wereld van verschil te maken voor onze patiënten! 🌏🧡 #azdelta #newsweek #ranking

This day 7 years ago, I underwent life saving surgery at UZ Leuven in Belgium. This message is a simple one, hope it helps. Positivity has played a huge role in my subsequent recovery. Sometimes it's hard to find but always there, you just gotta know where to look! #CarpeDiem

Great #EAU25 meeting with the colleagues of the Urology Department of AZ Delta!! Congratulations to our resident Eef Adriaensen presenting her research of urethroplasty performed UZ Leuven steven joniau, awarded best abstract of her session!!

Smarter staging in prostate cancer? 🙋🏼‍♂️🙋🏻‍♂️🙋🏾‍♂️In patients with intermediate/high-risk prostate cancer and negative PSMA PET (miN0), extended pelvic lymph node dissection (ePLND) remains a clinical dilemma. 🔍 This multi-institutional study (n = 282) externally validated five

tombal Amer. Urol. Assn. Hein Van Poppel steven joniau ESRU Belgium Maarten Albersen European Association of Urology (EAU) I’m surprised about the conclusions… should discuss them at BVU in december. Maarten Albersen

🌟Prostate Cancer: A Review (JAMA 2025)🌟 OncoAlert JAMA Oncology Advanced Prostate Cancer Consensus Conference A comprehensive update on epidemiology, diagnosis, and treatment of the most common nonskin cancer in men. ⚡ Most common nonskin cancer in men: 299,010 new US cases and 35,250 deaths in 2024 🧬 >50% of

Can treating all visible tumour sites improve outcomes in de novo omPC? Our new Rapid Review in Eur Urol Oncol discusses evidence for "total eradication of tumour" (TET)! 🧠 doi.org/10.1016/j.euo.… Pawel Rajwa steven joniau Tamas Fazekas MD Gert De Meerleer Giancarlo Marra Giorgio Gandaglia Shahrokh F. Shariat

📢 STORM trial breaking results at #ESTRO25! 🧪 MDT vs ENRT+MDT for nodal oligorecurrent PCa. 🧬 ENRT+MDT: ✅ Superior bRFS (57% vs 41%, p=0.014) ✅ Superior pelvic control (lrRFS 85% vs 62%, p=0.006) ✅ Superior MFS (76% vs 63%, p=0.06) ❌ No increase in ≥G2 GU/GI toxicity

Excited to share our latest paper on ARPI monotherapy in #ProstateCancer Eur Urol Focus EAU YAU Prostate Cancer Working Group Marcin Miszczyk Alexander Giesen Juan Gómez Rivas Axel S. Merseburger steven joniau Giancarlo Marra Nyirády Dr. Péter Giorgio Gandaglia Shahrokh F. Shariat Pawel Rajwa Semmelweis University Urologic Oncology Research MedUni Vienna tinyurl.com/48d4hdtk

A tactic of the anti lymph node dissection crowd is to exaggerate risks. In this case, a 17% risk of lymphocele is claimed, with a citation to a systematic review. The review included several papers showing risks of 2-3% and one small abstract showing 17%. pdf.sciencedirectassets.com/272280/1-s2.0-…

Spoke at #BeGUS2025 on updates in kidney & bladder cancer, featuring results from AURORAX-0087A Coh1 on #GAGomescore for ccRCC recurrence detection. Insightful panel discussion indeed. Thanks you organizers incl Eduard Roussel & steven joniau for the invite.

Saeed Dabestani Eduard Roussel Dear Saeed Saeed Dabestani , many thanks for sharing your insights and the results of AURORAX-0087A Coh1 at our BeGUS Summer Break ! Eduard Roussel Karel Decaestecker Thierry Roumeguere Marc Claessens Gert De Meerleer